In the field of epidemiology, metabolomics is used to understand the relationship between metabolic profiles and health outcomes across populations. By examining the metabolites found in biological samples such as blood, urine, or tissue, researchers can identify biomarkers that indicate the presence or risk of diseases, such as cardiovascular diseases, diabetes, and cancer. This can lead to improved disease prevention and management strategies.